Antiproliferative Effect of Aminoethyl-Chitooligosaccharide on Human Lung A549 Cancer Cells

Area of Science:

• Biochemistry
• Molecular Biology
• Oncology

Background:

• Aminoethyl-chitooligosaccharide (AE-COS) has demonstrated inhibitory effects on gastric cancer cell proliferation and fibrosarcoma cell invasion.
• Lung cancer remains a significant global health challenge, necessitating novel therapeutic strategies.

Purpose of the Study:

• To evaluate the antiproliferative and pro-apoptotic effects of AE-COS on human lung A549 cancer cells.
• To investigate the underlying molecular mechanisms of AE-COS action in lung cancer.

Main Methods:

• Human lung A549 cancer cells were treated with varying concentrations of AE-COS.
• Cell proliferation was quantified using standard assays.
• Expression levels of COX-2, Bcl-2, and activation of caspase-3 and -9 were assessed.

Main Results:

• AE-COS significantly reduced A549 cell proliferation by up to 68% at a concentration of 500 µg/ml.
• AE-COS treatment led to a dose-dependent suppression of cyclooxygenase-2 (COX-2) expression.
• AE-COS induced apoptosis by decreasing Bcl-2 expression and increasing the activation of caspase-3 and caspase-9.

Conclusions:

• AE-COS exhibits potent antiproliferative effects on human lung A549 cancer cells.
• The mechanism involves the suppression of COX-2 and induction of apoptosis via the caspase pathway.
• AE-COS shows promise as a novel chemotherapeutic agent for lung cancer.